Location History:
- Leics, GB (2004)
- Leics., GB (2005)
- Wymeswold, GB (2001 - 2008)
- Loughborough, GB (2004 - 2010)
Company Filing History:
Years Active: 2001-2010
Title: The Innovative Journey of Inventor Andrew Baxter
Introduction
Andrew Baxter, a distinguished inventor based in Loughborough, GB, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 13 patents. His work focuses on innovative compounds that target various medical conditions, particularly chemokine mediated diseases, demonstrating his commitment to advancing healthcare solutions.
Latest Patents
Among his latest innovations are patents for N-pyrazinyl-phenylsulphonamides, providing crucial compounds for the treatment of conditions such as asthma. These compounds, characterized by a specific formula, showcase Baxter's ability to create therapeutic solutions for inflammatory diseases. The invention encapsulates processes for preparation, pharmaceutical compositions, and their usage in therapy, reflecting the depth of research and development conducted by him.
Career Highlights
Baxter’s career is highlighted by his tenure at renowned companies such as AstraZeneca AB and AstraZeneca UK Limited. His work in these prestigious institutions has allowed him to further hone his expertise in medicinal chemistry and drug development, paving the way for numerous impactful inventions.
Collaborations
Throughout his career, Andrew Baxter has collaborated with notable professionals, including Thomas McInally and Nicholas David Kindon. These partnerships have enriched his projects, fostering a collaborative environment that has driven innovation in pharmaceutical research.
Conclusion
In conclusion, Andrew Baxter’s contributions to the field of pharmaceuticals through his patents and collaborative efforts illustrate the important role of inventors in addressing healthcare challenges. His ongoing dedication to innovation promises to influence future medical treatments, supporting patients with critical conditions.